Resources from the same session
Welcome and Introduction
Presenter: David Spigel
Session: AstraZeneca - Evolving strategies: Managing treatment of early stage and advanced lung cancers
Resources:
Webcast
Unresectable stage III NSCLC: Clinical advances in the implementation of immuno-oncology therapy
Presenter: Johan Vansteenkiste
Session: AstraZeneca - Evolving strategies: Managing treatment of early stage and advanced lung cancers
Resources:
Webcast
Early stage EGFRm NSCLC: Targeted treatment options following complete surgical resection
Presenter: Tom John
Session: AstraZeneca - Evolving strategies: Managing treatment of early stage and advanced lung cancers
Resources:
Webcast
Locally advanced or metastatic EGFRm NSCLC: Targeted treatment options to improve outcomes in the first-line setting and beyond progression
Presenter: David Planchard
Session: AstraZeneca - Evolving strategies: Managing treatment of early stage and advanced lung cancers
Resources:
Webcast